Can your smartwatch replace a medical heart test? scientists put apple watch to the test
NCT ID NCT07663799
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checks whether an Apple Watch Series 9 can accurately measure key health indicators—like oxygen levels and exercise capacity—in adults with heart conditions such as congenital heart disease, heart failure, or coronary artery disease. Participants wear the smartwatch during treadmill tests while medical-grade devices also record the same measurements. The goal is to see if consumer smartwatches are reliable enough for clinical use.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Apple Watch Series 9
- What this could lead to
- If accurate, smartwatches could help monitor heart disease progression at home, reducing clinic visits.
- What could go wrong
- This is a small, early validation study (20 participants) and may not prove accuracy for all patients or conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients having adult congenital heart disease or pulmonary hypertension, heart failure or coronary artery disease, or are athletes undergoing cardiovascular assessment
- Ages
-
20 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 20 to 70 years old * Ability to provide informed consent * History of the following cardiovascular conditions: * Adult congenital heart disease * Pulmonary hypertension * Heart failure * Coronary artery disease * Athletes undergoing cardiovascular assessment Exclusion Criteria: * Contraindication for undergoing physical exertion including cardio-pulmonary exercise testing (CPX) and 6-minute walk test (6MWT) * Pregnancy * Known allergy to components of the investigational product
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Apple watch are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Medicine, Queen Mary Hospital
Hong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- A soft patch that watches your heart beat in real time
- Can daily mindful breathing ease heart failure symptoms?
- Can a smartphone app keep heart failure patients out of the hospital?
- Can a warm wrist make baby arterial lines easier?
- A 10-Question survey could give brazilian pulmonary hypertension patients a voice in their care